Meanwhile, another pan‐HDAC inhibitor NAB (200 mg/kg) was chosen as a positive control in inv(16) AML cells‐bearing mice group because of its dominant position on the inhibition of HDAC‐8. Here, HDAC9 is linked to acute myeloid leukemia.